Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY.
According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology and Radiology segments growing by 24% YoY and 13% YoY respectively.
Also ReadBudget 2025 Expectations: Diagnostics sector leaders urge govt to strengthen public-private partnerships, offer tax incentives
Meanwhile, revenue from franchise surged by 24% YoY, and partnership revenue saw 23% YoY growth. The consolidated gross margin stood at 73%, and normalized EBITDA margin was 30%.
Also Read L&T Tech posts Q3 profit decline of 4.10% YoY to Rs 322.40 crore, revenue rises by 9.55% HCLTech misses estimates, profit up 8.4% to Rs 4,591 crore TCS Q3 Results Highlights: TCS Q3 profit jumps nearly 12%, dividends announced – Details here The first after listing: MobiKwik slips into loss of Rs 3.59 crore in Q2FY25, payments GMV up by 267.3% YoY
The company’s consolidated reported EBITDA grew by 32% YoY, while PAT increased by 30% YoY.
» Read More
